S&P 500   4,567.00
DOW   34,483.72
QQQ   393.82
S&P 500   4,567.00
DOW   34,483.72
QQQ   393.82
S&P 500   4,567.00
DOW   34,483.72
QQQ   393.82
S&P 500   4,567.00
DOW   34,483.72
QQQ   393.82

Cresco Labs Stock Forecast, Price & News

-0.23 (-2.74%)
(As of 11/30/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
630,788 shs
Average Volume
868,880 shs
Market Capitalization
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive CRLBF News and Ratings via Email

Sign-up to receive the latest news and ratings for Cresco Labs and its competitors with MarketBeat's FREE daily newsletter.

Cresco Labs logo

About Cresco Labs

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; flowers, popcorns, shakes, pre-rolls, and vapes under the High Supply brand; flowers, vapes, and edibles under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, ingestibles, sublingual oils, and transdermal patches under the Remedi brand, as well as cannabis products made from plants under the Reserve brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections, fruit-forward gummies, hard sweets, and taffy under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. It owns and operates 32 dispensaries, as well as 44 retail licenses. The company is headquartered in Chicago, Illinois.


See More Headlines

Industry, Sector and Symbol

Drug Manufacturers - Specialty & Generic
Current Symbol
Year Founded

Sales & Book Value

Annual Sales


Pretax Margin




Free Float
Not Optionable


Overall MarketRank

1.70 out of 5 stars

Analyst Opinion: 3.5Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Cresco Labs (OTCMKTS:CRLBF) Frequently Asked Questions

Is Cresco Labs a buy right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cresco Labs in the last twelve months. There are currently 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Cresco Labs stock.
View analyst ratings for Cresco Labs
or view top-rated stocks.

How has Cresco Labs' stock price been impacted by COVID-19?

Cresco Labs' stock was trading at $3.34 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, CRLBF stock has increased by 144.6% and is now trading at $8.1703.
View which stocks have been most impacted by COVID-19

Are investors shorting Cresco Labs?

Cresco Labs saw a increase in short interest in the month of October. As of October 29th, there was short interest totaling 441,800 shares, an increase of 22.1% from the October 14th total of 361,900 shares. Based on an average trading volume of 1,114,600 shares, the days-to-cover ratio is presently 0.4 days.
View Cresco Labs' Short Interest

What price target have analysts set for CRLBF?

6 equities research analysts have issued twelve-month target prices for Cresco Labs' shares. Their forecasts range from $19.00 to $36.00. On average, they anticipate Cresco Labs' share price to reach $25.50 in the next year. This suggests a possible upside of 212.1% from the stock's current price.
View analysts' price targets for Cresco Labs
or view top-rated stocks among Wall Street analysts.

Who are Cresco Labs' key executives?

Cresco Labs' management team includes the following people:
  • Mr. Charles Bachtell, Co-Founder, CEO & Director (Age 42, Pay $537.5k)
  • Mr. Dennis M. Olis, Chief Financial Officer (Age 58, Pay $202.12k)
  • Mr. Thomas J. Manning, Exec. Chairman (Age 64)
  • Mr. Robert M. Sampson, Co-Founder & Director (Age 46)
  • Mr. Ty Gent, Chief Operating Officer (Age 62)
  • Ms. Brenna Albert CPA, Sr. VP and Controller of Accounting, Treasury & Tax
  • Mr. Mo Dastagir, Chief Information Officer (Age 44)
  • Jake Graves, Mang. of Investor Relations
  • Mr. John Schetz, Gen. Counsel (Age 44)
  • Ms. Impola Kelli, VP of Compliance

What is Cresco Labs' stock symbol?

Cresco Labs trades on the OTCMKTS under the ticker symbol "CRLBF."

How do I buy shares of Cresco Labs?

Shares of CRLBF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cresco Labs' stock price today?

One share of CRLBF stock can currently be purchased for approximately $8.17.

How many employees does Cresco Labs have?

Cresco Labs employs 2,700 workers across the globe.

What is Cresco Labs' official website?

The official website for Cresco Labs is www.crescolabs.com.

Where are Cresco Labs' headquarters?

Cresco Labs is headquartered at 400 West Erie Street, Chicago, IL 60654.

This page was last updated on 12/1/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.